Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318) の利益

Beijing Bohui Innovation Biotechnology Group Co., Ltd. is a Chinese enterprise that manages the full spectrum of diagnostic product operations, from initial research and development through manufacturing, sales, and post-sale support. Their offerings include a variety of diagnostic tools such as the GenPlex microfluidic automated system for nucleic acid detection, immunofluorescence detection solutions, and products for analyzing human trace elements. Additionally, the company provides advanced chemical analysis instrumentation, featuring atomic fluorescence spectrometers, photometers, mass spectrometers, chip ion sources, microfluidic flow chemical analysis systems, and ICP spectroscopy equipment, along with vital consumables for life sciences. Founded in 2001, the company is headquartered in Beijing, China. It adopted its current name, Beijing Bohui Innovation Biotechnology Group Co., Ltd., in August 2021, having previously been known as Beijing Bohui Innovation Biotechnology Co., Ltd.

年	利益	変化
提供された日付のデータは十分ではありません。

年

利益

変化

提供された日付のデータは十分ではありません。

企業	利益	利益の差	国
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
CSL Limited CSL.AX	$-4.02B	-	AU
Moderna, Inc. MRNA.US	$-3.09B	-	US
Lonza Group AG LONN.SW	-	-	CH

企業

利益

利益の差

国